X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs FRESENIUS KABI ONCO. - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA FRESENIUS KABI ONCO. FULFORD INDIA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 398.8 22.1 1,801.9% View Chart
P/BV x 6.2 3.1 199.7% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 FULFORD INDIA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
FRESENIUS KABI ONCO.
Mar-13
FULFORD INDIA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs942176 535.2%   
Low Rs45079 573.2%   
Sales per share (Unadj.) Rs691.437.7 1,834.6%  
Earnings per share (Unadj.) Rs11.55.1 225.0%  
Cash flow per share (Unadj.) Rs15.46.7 228.4%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.30-  
Book value per share (Unadj.) Rs380.042.5 893.2%  
Shares outstanding (eoy) m3.90158.23 2.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.8%   
Avg P/E ratio x60.725.0 243.1%  
P/CF ratio (eoy) x45.318.9 239.4%  
Price / Book Value ratio x1.83.0 61.2%  
Dividend payout %17.40-   
Avg Mkt Cap Rs m2,71420,135 13.5%   
No. of employees `0000.41.2 38.5%   
Total wages/salary Rs m505703 71.8%   
Avg. sales/employee Rs Th6,073.05,176.2 117.3%   
Avg. wages/employee Rs Th1,137.4610.4 186.3%   
Avg. net profit/employee Rs Th100.7699.6 14.4%   
INCOME DATA
Net Sales Rs m2,6965,963 45.2%  
Other income Rs m12518 696.7%   
Total revenues Rs m2,8225,981 47.2%   
Gross profit Rs m-461,430 -3.2%  
Depreciation Rs m15258 5.9%   
Interest Rs m10-26 -36.5%   
Profit before tax Rs m541,216 4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m10342 2.8%   
Profit after tax Rs m45806 5.5%  
Gross profit margin %-1.724.0 -7.2%  
Effective tax rate %17.728.1 62.8%   
Net profit margin %1.713.5 12.3%  
BALANCE SHEET DATA
Current assets Rs m1,7385,102 34.1%   
Current liabilities Rs m5452,385 22.8%   
Net working cap to sales %44.345.6 97.2%  
Current ratio x3.22.1 149.2%  
Inventory Days Days48150 32.3%  
Debtors Days Days4113 3.8%  
Net fixed assets Rs m125,148 0.2%   
Share capital Rs m39158 24.7%   
"Free" reserves Rs m1,4436,556 22.0%   
Net worth Rs m1,4826,732 22.0%   
Long term debt Rs m0952 0.0%   
Total assets Rs m2,07710,388 20.0%  
Interest coverage x6.7-45.8 -14.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 226.2%   
Return on assets %2.67.5 34.8%  
Return on equity %3.012.0 25.2%  
Return on capital %4.314.6 29.5%  
Exports to sales %074.5 0.0%   
Imports to sales %24.524.8 98.7%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs m6591,477 44.6%   
Fx inflow Rs m175,298 0.3%   
Fx outflow Rs m6731,772 38.0%   
Net fx Rs m-6563,525 -18.6%   
CASH FLOW
From Operations Rs m901,274 7.1%  
From Investments Rs m105-1,204 -8.7%  
From Financial Activity Rs m-14-196 7.2%  
Net Cashflow Rs m181-126 -142.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 81.0 92.6%  
Indian inst/Mut Fund % 3.8 0.3 1,266.7%  
FIIs % 0.1 9.6 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 9.1 233.0%  
Shareholders   4,783 42,599 11.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   IPCA LABS  NOVARTIS  ALEMBIC PHARMA  MERCK LTD  SANOFI INDIA  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Energy Stocks Witness Buying(11:30 am)

After opening the day in green, Share markets in India witnessed volatile trading activity and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - BIOCON LTD COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS